Optogenetic Control of Oncogenic Signaling in B-Cell Malignancies

被引：0
|
作者：
Kume, Kohei [1 ]
Lee, Jaewoong [1 ,2 ]
Cheng, Zhangliang [1 ]
Robinson, Mark E. [1 ]
Leveille, Etienne [1 ]
Cosgun, Kadriye Nehir [1 ]
Chan, Lai N. [1 ]
Feng, Yanzhi [1 ]
Fonseca, David [1 ]
Khanduja, Dhruv [1 ]
Toomre, Derek [3 ]
Muschen, Markus [1 ]
机构：
[1] Yale Univ, Ctr Mol & Cellular Oncol, New Haven, CT USA
[2] Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea
[3] Yale Univ, Dept Cell Biol & Biophys, New Haven, CT USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] B-cell receptor signaling in lymphoid malignancies - oncogenic driver and therapeutic target
    Schmitt, C.
    Oncology Research and Treatment, 2015, 38 : 87 - 88
  • [2] Dynamic Recruitment of Inhibitory Complexes Controls Oncogenic Signaling in B-Cell Malignancies
    Sun, Ruifeng
    Lee, Jaewoong
    Robinson, Mark E.
    Kume, Kohei
    Ma, Ning
    Cosgun, Kadriye Nehir
    Chan, Lai N.
    Antoshkina, Irina
    Khanduja, Dhruv
    Leveille, Etienne
    Katz, Samuel G.
    Chen, Jianjun
    Paietta, Elisabeth
    Vaidehi, Nagarajan
    Muschen, Markus
    BLOOD, 2023, 142
  • [3] Dual inhibition of oncogenic targets for B-cell malignancies
    Richardson, Paul G.
    LANCET ONCOLOGY, 2016, 17 (05): : 547 - 549
  • [4] CD25-Dependent Feedback Control of the B-Cell Receptor and Its Oncogenic Mimics in B-Cell Malignancies
    Lee, Jae-Woong
    Kume, Kohei
    Chen, Zhengshan
    Xiao, Gang
    Cosgun, Kadriye Nehir
    Chan, Lai N.
    Chen, Chun-Wei
    Pillai, Raju
    Chan, Wing C.
    Forman, Stephen J.
    Kwak, Larry W.
    Zammarchi, Francesca
    Van Berkel, Patrick
    Weinstock, David M.
    Melnick, Ari M.
    Ngo, Vu N.
    Geng, Huimin
    Luger, Selina
    Litzow, Mark R.
    Belot, Alexandre
    Uzel, Gulbu
    McManus, Michael T.
    Paietta, Elisabeth M.
    Meffre, Eric
    Muschen, Markus
    BLOOD, 2018, 132
  • [5] Inhibitors of B-Cell Receptor Signaling for Patients With B-Cell Malignancies
    Choi, Michael Y.
    Kipps, Thomas J.
    CANCER JOURNAL, 2012, 18 (05): : 404 - 410
  • [6] B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies
    Koehrer, Stefan
    Burger, Jan A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 55 - 65
  • [7] Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Soysal, Teoman
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (06) : 765 - 783
  • [8] Co-Expression of SYK and ZAP70 Subverts Negative B-Cell Selection and Enables Oncogenic Signaling in Multiple B-Cell Malignancies
    Sadras, Teresa
    Martin, Mickael
    Kim-Sing, Lauren
    Cutler, Jevon
    Lenz, Gal
    Knapp, Anne Marie
    Ghergus, Dana
    Delmotte, Fabien
    Schleiss, Cedric
    Korganow, Anne-Sophie
    Soulas-Sprauel, Pauline
    Chen, Zhengshan
    Pandey, Akhilesh
    Weinstock, David M.
    Jumaa, Hassan
    Meffre, Eric
    Martin, Thierry
    Muschen, Markus
    BLOOD, 2019, 134
  • [9] B-Cell Receptor Signaling in Lymphoid Malignancies and Autoimmunity
    Avalos, Ana M.
    Meyer-Wentrup, Friederike
    Ploegh, Hidde L.
    CELL BIOLOGY OF THE B CELL RECEPTOR, 2014, 123 : 1 - 49
  • [10] B-cell receptor signaling in the pathogenesis of lymphoid malignancies
    Bojarczuk, Kamil
    Bobrowicz, Malgorzata
    Dwojak, Michal
    Miazek, Nina
    Zapala, Piotr
    Bunes, Anders
    Siernicka, Marta
    Rozanska, Maria
    Winiarska, Magdalena
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (03) : 255 - 265
12345